| NCT Number | NCT07321704 |
| Lead Sponsor | Yosef Nasseri, MD
Collaborators: Irrimax Corporation |
| Conditions | Pilonidal Disease |
| Enrollment | 60 participants |
| Start Date | 2026-02-17 |
| Primary Completion | 2027-06-01 (estimated) |
| Study Completion | 2027-12-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-27 |